ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills

November 8, 2002

NCI Approved Clinical Trials

May 28, 2010

Hoogstraten Resignation Sidetracks Kansas’ Move to Comprehensive Status, Threatens Core Grant

February 15, 1980

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

NCAB Gives Okay To Comp Center Guidelines

December 7, 1979